Healthy Adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the research, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate 2. Persons who are male or female and 18 years old or more at the time of obtaining consent 3. Persons who are able to participate in Yosakoi practice 4. Persons who do not have intestinal diseases (including those who are judged not to require immediate treatment)
Exclusion criteria
Exclusion criteria: 1. Persons who may experience stomach pain when eating foods containing oligosaccharides 2. Persons who have been diagnosed with a digestive disease (digestive diseases accompanied by digestive inflammation, including inflammatory bowel disease (IBD)), previously undergone digestive surgery, and will require digestive surgery in the future 3. Persons who regularly use materials containing oligosaccharides (3 days or more per week) or have regularly used them within one month prior to the pre-test 4. Persons who have been diagnosed with malignant tumors, currently receiving treatment for cranial nerve, heart, kidney, diabetes, or thyroid dysfunction, and with a history of serious illnesses such as liver disease, at risk for cardiovascular disease, excluding illnesses which principal investigator determined will not affect the evaluation of the research. 5. Persons who drink a large amount of alcohol (60 g or more of alcohol per day: approximately 1500 mL of beer, 540 mL of wine, 3 cups of sake, or 180 mL of double-sized whiskey) 6. Persons who are at risk of developing allergies related to the test foods 7. Persons who are judged unsuitable as research subjects based on their responses to a background survey 8. Persons who have participated in other research during one month prior to the start of this research, or plan to participate in other research after consenting to this research. 9. Persons who are judged to be ineligible by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal microbiota after 8 weeks of intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life (QOL) questionnaires after 8 weeks of intake | — |
Countries
Japan
Contacts
BIOSIS Lab. Co., Ltd. CEO